Marex Group’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Marex Group’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,433	Closed	-$25K	–	800
2024 Q2	$25K	Buy	10,433 +12	+0.1%	+$43	﹤0.01%	608
2024 Q1	$51.3K	Buy	+10,421	New	+$52.2K	﹤0.01%	448

Other funds holding ASLN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Marex Group's ASLN Position: Q3 2024 in Review

Marex Group sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 10,433 shares — an estimated $25K sold.

Marex Group first reported a position in ASLN in Q1 2024 and held it in 2 quarters. The position peaked at $51.3K in Q1 2024. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

Marex Group reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
Marex Group sold 10,433 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $25K.
Marex Group first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2024 and held it in 2 quarters.
Marex Group's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $51.3K in Q1 2024.
1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on Marex Group's 13F filing for Q3 2024, filed 7 Apr 2026.